Approximately 30 million J&J vaccines will be produced at the Aspen facility



[ad_1]

Ramaphosa was speaking on the sidelines of an inspection of the institution in Gqeberha on Monday afternoon.

President Cyril Ramaphosa. Image: Abigail Javier / Eyewitness News.

JOHANNESBURG – President Cyril Ramaphosa announced that South Africa will have access to some 30 million Johnson and Johnson vaccines, which will be produced at the Aspen manufacturing facility in the Eastern Cape.

Ramaphosa was speaking on the sidelines of an inspection of the institution in Gqeberha on Monday afternoon.

The company is expected to reinforce the country’s fight against COVID-19 by assisting in the production of vaccines.

He said South Africa must position itself to be able to receive the doses produced in the country.

The visit comes in the context of criticism that the government has screwed up the country’s vaccination program due to lack of planning.

Ramaphosa said there was an urgent need for vaccine administration across the country.

More than 230,000 healthcare workers have been vaccinated in the country as part of the Johnson and Johnson implementation study.

“This Aspen belongs to us as South Africans and is making life-saving vaccines and we, as South Africa, must be in the first place to get the vaccines that are made here.”



Download the Eyewitness News app on your iOS or Android device.



[ad_2]